Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Clinical manifestations and diagnosis of familial Mediterranean fever

Stephen E Goldfinger, MD
Section Editor
Lawrence S Friedman, MD
Deputy Editors
Shilpa Grover, MD, MPH
Monica Ramirez Curtis, MD, MPH


Familial Mediterranean fever (FMF) is a hereditary autoinflammatory disorder characterized by recurrent bouts of fever and serosal inflammation. This topic will review the clinical manifestations and diagnosis of FMF. The epidemiology, genetics, pathophysiology, and management of FMF and an overview of periodic fever syndromes and other autoinflammatory diseases can be found elsewhere. (See "Familial Mediterranean fever: Epidemiology and pathogenesis" and "Management of familial Mediterranean fever" and "Periodic fever syndromes and other autoinflammatory diseases: An overview".)


Familial Mediterranean fever (FMF) is characterized by sporadic, unpredictable attacks of fever and serosal inflammation. Most patients with FMF experience their first attack in early childhood. The initial attack occurs before the ages of 10 and 20 years in 65 and 90 percent of cases, respectively [1]. However, in rare cases the initial attack can occur in individuals older than 50 years of age.

Recurrent fever — Patients with FMF have recurrent episodes of fever and severe pain (due to serositis at one or more sites). The onset of pain and fever is usually abrupt, peaking soon after onset. Many patients have a stereotypic prodrome before their attacks [2]. Episodes last for one to three days and then resolve spontaneously. In between attacks, patients are asymptomatic. The frequency of attacks is highly variable, even in a given patient, and it is unusual for a patient to describe a consistent triggering event. Vigorous exercise, exposure to cold, emotional stress, fatigue, surgery, and menstruation have been associated with an attack in some patients. However, many patients have no clear precipitant. Attacks during pregnancy usually abate during the second half. The intervals between episodes are irregular, ranging from one week to several months or years. [3]

Abdominal pain — Ninety-five percent of patients with FMF have episodic abdominal pain [1]. Abdominal pain and tenderness may initially be localized and then progress to become more generalized. Guarding, rebound tenderness, rigidity, and an adynamic ileus are often present. These findings can be mistaken for an acute surgical abdomen. (See "Evaluation of the adult with abdominal pain".)

Chest pain — Painful FMF attacks are localized to the chest in approximately 45 percent of patients. Chest pain may be due to inflammation of the pleura or referred pain from subdiaphragmatic inflammation. Pleural inflammation typically manifests as unilateral chest pain that is worse with inspiration or coughing. Patients often have a small, transient pleural effusion. Episodes usually resolve within three days, but may last up to one week. Concomitant pericarditis can also be observed in patients with pleuritis.


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Dec 2016. | This topic last updated: Mon Nov 30 00:00:00 GMT+00:00 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
  1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967; 43:227.
  2. Lidar M, Yaqubov M, Zaks N, et al. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 2006; 33:1089.
  3. Kucuk A, Gezer IA, Ucar R, Karahan AY. Familial Mediterranean Fever. Acta Medica (Hradec Kralove) 2014; 57:97.
  4. Garcia-Gonzalez A, Weisman MH. The arthritis of familial Mediterranean fever. Semin Arthritis Rheum 1992; 22:139.
  5. Drenth JP, van der Meer JW. Hereditary periodic fever. N Engl J Med 2001; 345:1748.
  6. Lidar M, Doron A, Barzilai A, et al. Erysipelas-like erythema as the presenting feature of familial Mediterranean fever. J Eur Acad Dermatol Venereol 2013; 27:912.
  7. Majeed HA, Quabazard Z, Hijazi Z, et al. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. Q J Med 1990; 75:607.
  8. Bayram MT, Çankaya T, Bora E, et al. Risk factors for subclinical inflammation in children with Familial Mediterranean fever. Rheumatol Int 2015; 35:1393.
  9. Kees S, Langevitz P, Zemer D, et al. Attacks of pericarditis as a manifestation of familial Mediterranean fever (FMF). QJM 1997; 90:643.
  10. Eshel G, Vinograd I, Barr J, Zemer D. Acute scrotal pain complicating familial Mediterranean fever in children. Br J Surg 1994; 81:894.
  11. Ertekin V, Selimoğlu MA, Alp H, Yilmaz N. Familial Mediterranean fever protracted febrile myalgia in children: report of two cases. Rheumatol Int 2005; 25:398.
  12. Capron J, Grateau G, Steichen O. Is recurrent aseptic meningitis a manifestation of familial Mediterranean fever? A systematic review. Clin Exp Rheumatol 2013; 31:127.
  13. Rigante D, Lopalco G, Tarantino G, et al. Non-canonical manifestations of familial Mediterranean fever: a changing paradigm. Clin Rheumatol 2015; 34:1503.
  14. van der Hilst JC, Simon A, Drenth JP. Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 2005; 5:87.
  15. HELLER H, SOHAR E, GAFNI J, HELLER J. Amyloidosis in familial Mediterranean fever. An independent genetically determined character. Arch Intern Med 1961; 107:539.
  16. Pras M. Amyloidosis of familial mediterranean fever and the MEFV gene. Amyloid 2000; 7:289.
  17. Tunca M, Akar S, Onen F, et al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 2005; 84:1.
  18. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351:659.
  19. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 1997; 90:797.
  20. Medlej-Hashim M, Delague V, Chouery E, et al. Amyloidosis in familial Mediterranean fever patients: correlation with MEFV genotype and SAA1 and MICA polymorphisms effects. BMC Med Genet 2004; 5:4.
  21. Babior BM, Matzner Y. The familial Mediterranean fever gene--cloned at last. N Engl J Med 1997; 337:1548.
  22. Booty MG, Chae JJ, Masters SL, et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 2009; 60:1851.
  23. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40:1879.
  24. Yalçinkaya F, Ozen S, Ozçakar ZB, et al. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology (Oxford) 2009; 48:395.
  25. Ozçakar ZB, Yalçınkaya F, Cakar N, et al. Application of the new pediatric criteria and Tel Hashomer criteria in heterozygous patients with clinical features of FMF. Eur J Pediatr 2011; 170:1055.
  26. Kondi A, Hentgen V, Piram M, et al. Validation of the new paediatric criteria for the diagnosis of familial Mediterranean fever: data from a mixed population of 100 children from the French reference centre for auto-inflammatory disorders. Rheumatology (Oxford) 2010; 49:2200.
  27. Samuels J, Aksentijevich I, Torosyan Y, et al. Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health. Medicine (Baltimore) 1998; 77:268.
  28. Padeh S, Shinar Y, Pras E, et al. Clinical and diagnostic value of genetic testing in 216 Israeli children with Familial Mediterranean fever. J Rheumatol 2003; 30:185.